Trinity Biotech PE Ratio 2006-2019 | TRIB

Current and historical p/e ratio for Trinity Biotech (TRIB) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Trinity Biotech PE ratio as of August 23, 2019 is 0.00.
Trinity Biotech PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2019-08-23 1.45 0.00
2019-06-30 1.65 $-0.90 0.00
2019-03-31 2.85 $-0.87 0.00
2018-12-31 2.29 $-0.84 0.00
2018-09-30 4.00 $-1.52 0.00
2018-06-30 5.00 $-1.53 0.00
2018-03-31 5.15 $-1.52 0.00
2017-12-31 5.10 $-1.49 0.00
2017-09-30 5.61 $-3.62 0.00
2017-06-30 6.00 $-3.66 0.00
2017-03-31 5.96 $-3.61 0.00
2016-12-31 6.92 $-3.72 0.00
2016-09-30 13.22 $0.11 120.18
2016-06-30 11.34 $0.66 17.18
2016-03-31 11.66 $0.67 17.40
2015-12-31 11.76 $0.90 13.07
2015-09-30 11.44 $0.98 11.67
2015-06-30 18.06 $0.63 28.67
2015-03-31 19.02 $0.71 26.78
2014-12-31 17.30 $0.72 24.02
2014-09-30 18.05 $0.73 24.72
2014-06-30 22.75 $0.42 54.17
2014-03-31 23.72 $0.41 57.85
2013-12-31 24.61 $0.41 60.02
2013-09-30 21.30 $0.42 50.71
2013-06-30 16.49 $0.75 21.99
2013-03-31 16.33 $0.77 21.21
2012-12-31 13.95 $0.78 17.89
2012-09-30 12.16 $0.76 16.00
2012-06-30 11.61 $0.74 15.69
2012-03-31 10.19 $0.72 14.15
2011-12-31 9.72 $0.70 13.89
2011-09-30 8.75 $0.69 12.68
2011-06-30 9.49 $0.65 14.60
2011-03-31 8.87 $2.88 3.08
2010-12-31 8.33 $2.86 2.91
2010-09-30 5.98 $2.84 2.11
2010-06-30 5.75 $2.84 2.02
2010-03-31 5.15 $0.58 8.88
2009-12-31 3.82 $0.55 6.94
2009-09-30 3.73 $-3.52 0.00
2009-06-30 4.18 $-3.60 0.00
2009-03-31 1.65 $-3.67 0.00
2008-12-31 1.51 $-3.73 0.00
2008-09-30 2.67 $-1.96 0.00
2008-06-30 3.65 $-2.02 0.00
2008-03-31 4.34 $-1.95 0.00
2007-12-31 6.44 $-1.86 0.00
2007-09-30 9.93 $0.38 26.12
2007-06-30 10.97 $0.52 21.09
2007-03-31 8.58 $0.26 33.02
2006-12-31 8.10 $0.19 42.65
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.036B $0.097B
Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and Amax, comprising test kits and instrumentation used for the detection of blood disorders. These products are used to detect autoimmune, infectious and sexually transmitted diseases, diabetes and disorders of the blood, liver and intestine. The Company is also a provider of raw materials to the life sciences industry. It also engages in the provision of engineering, financial, and management services, as well as in trading business. Trinity Biotech sells its products through its sales force, as well as through a network of distributors and strategic partners.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.115B 28.03
Medtronic (MDT) Ireland $144.617B 20.31
Stryker (SYK) United States $81.656B 28.24
Boston Scientific (BSX) United States $59.466B 28.84
Baxter (BAX) United States $44.526B 27.00
EssilorLuxottica Societe Anonyme (ESLOY) France $31.586B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.151B 18.02
Coloplast (CLPBY) Denmark $26.697B 42.62
Lonza Group Ag (LZAGY) Switzerland $26.607B 0.00
Terumo (TRUMY) Japan $23.560B 27.09
Smith & Nephew SNATS (SNN) United Kingdom $20.735B 0.00
ResMed (RMD) United States $19.545B 37.27
Sunny Optical Technology (SNPTF) China $14.643B 0.00
Bio-Rad Laboratories (BIO) United States $10.190B 54.63
Insulet (PODD) United States $9.354B 554.25
Canopy Growth (CGC) Canada $8.712B 0.00
William Demant Holdings (WILYY) Denmark $7.136B 0.00
Hill-Rom Holdings (HRC) United States $7.062B 21.06
Haemonetics (HAE) United States $6.793B 51.26
Perrigo (PRGO) Ireland $6.499B 11.97
GN STORE NORD (GNNDY) Denmark $6.001B 30.65
Aurora Cannabis (ACB) Canada $5.891B 57.90
GW Pharmaceuticals (GWPH) United Kingdom $4.444B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Neogen (NEOG) United States $3.753B 62.43
ICU Medical (ICUI) United States $3.439B 22.31
NuVasive (NUVA) United States $3.400B 27.10
Hutchison China MediTech (HCM) China $2.737B 0.00
Quidel (QDEL) United States $2.520B 25.02
Agios Pharmaceuticals (AGIO) United States $2.458B 0.00
National Vision Holdings (EYE) United States $2.257B 48.71
Cardiovascular Systems (CSII) United States $1.754B 0.00
Aphria (APHA) $1.634B 0.00
Phibro Animal Health (PAHC) United States $1.288B 19.30
AtriCure (ATRC) United States $1.035B 0.00
VAREX IMAGING (VREX) United States $1.028B 23.68
Omeros (OMER) United States $0.992B 0.00
PetIQ (PETQ) United States $0.900B 21.27
NanoString Technologies (NSTG) United States $0.896B 0.00
Lantheus Holdings (LNTH) United States $0.885B 23.25
Eagle Pharmaceuticals (EGRX) United States $0.796B 20.29
Cerus (CERS) United States $0.758B 0.00
MacroGenics (MGNX) United States $0.739B 0.00
Quanterix (QTRX) United States $0.667B 0.00
LeMaitre Vascular (LMAT) United States $0.624B 37.00
Surmodics (SRDX) United States $0.600B 114.08
TG Therapeutics (TGTX) United States $0.596B 0.00
OraSure Technologies (OSUR) United States $0.439B 20.34
Meridian Bioscience (VIVO) United States $0.410B 12.81
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.398B 0.00
BioLife Solutions (BLFS) United States $0.394B 129.63
United Health Products (UEEC) United States $0.374B 0.00
Utah Medical Products (UTMD) United States $0.346B 25.35
Zynex (ZYXI) United States $0.317B 33.65
Owens & Minor (OMI) United States $0.303B 9.09
Bovie Medical (APYX) United States $0.250B 0.00
Vapotherm (VAPO) United States $0.225B 0.00
Cytosorbents (CTSO) United States $0.160B 0.00
Fonar (FONR) United States $0.155B 8.16
Rockwell Medical (RMTI) United States $0.152B 0.00
Chimerix (CMRX) United States $0.144B 0.00
Female Health (VERU) United States $0.129B 0.00
United-Guardian (UG) United States $0.089B 21.08
Chembio Diagnostics (CEMI) United States $0.087B 0.00
Surface Oncology (SURF) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
Nephros (NEPH) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.028B 0.00
Valeritas Holdings (VLRX) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
GUARDION HEALTH (GHSI) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00